Journal Information

Journal Policies and Operations Procedures

  • Becoming a reviewer
  • Governance
  • Peer review policy
    • Plagiarism check/Rejections
    • Timely reviews
    • Why are Manuscripts Rejected?
    • Reviewer’s check list
    • Writing a review
    • Reviewer Identities
    • Revisions
    • Editorial decisions and appeals
    • Reviewing feature articles, opinions and blog posts
    • Appeals
    • Communication with Reviewers
  • Unlabeled use
  • Content validation
  • Patient consent
  • Statistical analysis
  • Data sharing, reproducibility and data repositories
  • Self-archiving of papers
  • Ethical publishing practices
  • Plagiarism
  • Misconduct

 

Peer Review  

Becoming a reviewer

Due to the nature of this developing sector, TMT continually seeks and obtains advice and guidance from outside expert reviewers to enhance the open access journal and ensure appropriate and timely manuscript reviews to promote trusted, ethical scholarly communication and academic contribution to the evolving field. Reviewers are selected based on expertise in blockchain and DLT platforms, information systems, clinical computing, network technologies in the biomedical sciences and healthcare sectors. They are expected to abide by a code of ethics regarding honesty. TMT expects reviewers to report the conduct of unethical research or false scientific communications practices. Reviewers will provide prompt, confidential, objective comments and manuscript reviews that contribute to ongoing and final TMT editorial decisions and best practices. Reviewers will abide by the Ethical Guidelines for Peer Reviewers ascribed by COPE. Conflict of Interest (COI) is located here.

Editors are selected either by self-nomination, or by nominations that are made from the Editors-in-Chief, Editorial Board and publisher whereby reviews of letters, curriculum vitaes and interviews are conducted with the candidate and/or colleagues and experts in the field from around the world.  TMT seeks multidisciplinary experts and practitioners of the highest caliber and passion in the field, and prefers candidates that possess knowledge of academic journal workflow and familiarity with the peer review process. 

To become a TMT peer reviewer, please send a letter to the editor including attestation of no affiliation(s) with suspected predatory journals or publisher(s) with your CV attached to info@partnersindigitalhealth.com

The reviewer role includes reviewing manuscripts, providing journal policy advice, identifying topics of interest or new research protocols and innovation, attracting new and established authors and researchers, building awareness for journal and contributing their own work and expertise.

Governance

The Managing Editor conducts plagiarism checks, ensures editorial and research writing standards, timely ethical peer review, scholarly guidelines and practices are adhered as ascribed by ICMJE, COPE and WAME. Editors-in-Chief and Associate Editors-in-Chief assess manuscript submission quality, technical, health innovation, education and market merits, while all editorial board members and reviewers may assess and provide rigorous double blind peer review and constructive feedback for authors. All members abide by publishing ethics guidelines ascribed by COPE to ensure the highest standards are adhered to.

Peer review policy

Plagiarism detection/Rejections

TMT is a member CrossRef and Similarity Check, iThenticate. The Similarity Check plagiarism software is used to verify originality of content at the manuscript submission stage. All submissions are first checked to determine if any and how much plagiarized content is contained in a manuscript submission by the Managing Editor. If plagiarism is detected, the submission is returned to the author with comment(s) including the reported percent of plagiarized content, or rejected outright by the Managing Editor based solely on the plagiarism check. Editor(s)-in-Chief will then review and approve papers that pass the plagiarism-check to determine whether the submission should be routed for peer review.

Timely reviews

TMT recognizes speed to publication is important to authors. Once a submission has been accepted for peer review, two (2) to three (3) expert reviewers are asked to assess the merits of the work and provide feedback. Reviewer feedback is communicated to the corresponding author by the Managing Editor.

Two peer reviewers must accept the paper for publication, or provide commentary for revisions requiring a resubmission. If we do not possess board expertise to conduct a review, we will ask the author for suggestions for expert reviewers, and invite them to act as expert guest reviewer for the submission. This may delay the review process. The managing editor will inform authors to expect delays if inviting a guest reviewer is required.

TMT strives to ensure peer review is fair, unbiased and timely. TMT endeavors to provide the initial manuscript expert review in 14 business days from submission. Reviews for subsequent rounds are also 14 days. All manuscripts and associated material submitted to TMT remain confidential while under review.

Why are Manuscripts Rejected?

The Managing Editor will reject a submission if a manuscript is poorly formatted, scholarly language communication is deficient, lacks substantiating claims, appears to have large portions plagiarized, or is not referenced in the Vancouver style. In most cases, the Managing Editor will recommend and communicate correction(s). Editors-in-Chief will reject a submission that rehashes general information already in the public domain. If peer reviewers reject a manuscript (based on criteria below), the Managing Editor will alert the corresponding author and send blinded reviewer comments explaining why the manuscript was rejected. Previously published materials and white papers are not acceptable unless COPE guidelines are strictly followed. Contact the Managing Editor with questions at j.russo@partnersindigitalhealth.com

Reviewer’s check list

TMT reviewers are expected to recuse themselves if they have a potential competing interest, including the following:

  • Prior or current collaborations with the author(s) if known
  • Reviewer is a direct competitor
  • Reviewer may have a known history of antipathy with the author(s)
  • Reviewer may profit financially from the work

Reviewers will not accept a peer review invitation should a conflict exist and will decline the review invitation whereby the managing editor will invite an alternate reviewer.

Writing the review

The purpose of the review is to provide the Editors-in-Chief, Associate Editors-in-Chief and Managing Editor with expert opinion regarding the quality of the manuscript, and authors with clear and concise constructive feedback on how to improve papers so that they may become acceptable for publication. Reviewers will abide by the Ethical Guidelines for Peer Reviewers ascribed by COPE.

All reviewer comments are anonymous and communicated to the author by the Managing Editor as Reviewer 1, 2, 3 etc.. Reviewers are asked to consider the following when reviewing a submission:

  • What are the main claims of the paper and how important are they?
  • Are these claims novel? If not, specify papers that weaken the claims to the originality of this one.
  • Are claims properly placed in the context of previous literature?
  • Do results support claims? If not, what other evidence is required?
  • Would other experiments or information improve the paper? Would it significantly improve the paper to do more work?
  • Is the paper outstanding in its discipline? What makes it so? If not, why?
  • Who would find this paper of interest? Why?
  • Does it suit the journal’s audience?
  • If the paper is unsuitable for publication in its present form, is there potential to encourage the author to resubmit a revised version?

Reviewers are asked to be matter of fact, clear and concise with their comments in addition to accepting, rejecting or requiring revisions to the manuscript submission.

Reviewer Identities

Reviewers’ identities are anonymous. TMT Peer Review is anonymous and double blind. All manuscripts submitted for publication undergo peer review including those submitted by editorial board members, regular columns, features and op/eds, and themed issues. Editorials, publisher letters, annual Prediction articles and BLOGS do not undergo peer review. 

Authors can request to exclude a specific reviewer from reviewing their manuscript as long as TMT peer review process remains intact and a thorough assessment of the manuscript is given. A decision letter is sent to the author when all reviews are received and considered by the Managing Editor after each review round.

Revisions

The Managing Editor and reviewers assess revised manuscripts to ensure all reviewers' comments were addressed for re-submission review and/or explanations are provided where a suggested revision was not corrected or addressed. Revisions are generally requested if a manuscript is considered appropriate. Minor revisions are usually requested as a final step before acceptance in the production phase. If manuscripts are rejected by reviewers, the Managing Editor will relay anonymous reviewer comments to the submitting author.

Editorial decisions

Should reviewers reject a submission or resubmission, the Managing Editor may alert the Editors-in-Chief (EICs) and Associate Editors-in-Chief to determine whether the EICs believe the submission warrants publication and benefits the sector. The EICs and Managing Editor will, together, make a decision based on the reviewers' comments, and may contact the reviewers to discuss the overall manuscript contribution in the field in more depth. EIC decisions are final.

Appeals

To appeal a decision, authors can contact the Managing Editor and explain the reason(s) for the appeal. When a paper has been revised in response to the review, or when authors appeal against a decision, we ask reviewers to provide commentary.

All appeals are discussed with the Editors-in-Chief and reviewers assigned to the submission.  In the case of disagreement, TMT may seek external advice on the appeal, but it is most likely the final decision will be left to the Editors-in-Chief.

Only one appeal will be considered. The Editors-in Chief decision will be final.

Reviewing Feature article and Opinion submissions

TMT reviewers are asked to review these submissions considering the following:

  • Is the article relevant and of interest to an international audience?
  • Does it address a global and topical subject? Will it be relevant across demographic populations?
  • Is the article well written, clear, and easy for a non-specialist?
  • Does the reviewer think the article will impact clinicians, researchers, health policymakers, or the public? Will it be widely read, disseminated, or cited? Could it improve public and/or global health? Will media outlets find it news worthy?
  • Is the article accurate? Are claims evidence-based?
  • Has the author missed anything important?
  • Does the article contain new information warranting publication? Does it take a discussion or debate into a new direction? Does it challenge current legacies?
  • Is it written in a scholarly format? Is it referenced in the Vancouver style?
  • If tables and figures are included, do they help the reader, or hinder topic and focus? How can they be improved?

Appeals

For feature/opinion articles, TMT editorial judgment for readability and engagement is decidedly important. An appeal is less likely to overturn a TMT editorial decision for feature/opinion articles. Authors are welcome to submit a detailed rebuttal letter. Only one appeal will be considered. The Editors-in Chief’s decision will be final.

Communication with Reviewers

New editorial team members are sent details regarding basic journal workflow and operations, expectations, requirements and links to COPE and ICMJE to further emphasize familiarity with journal operations, workflow, the importance of ethics, peer review role and expectation and best practices. In addition, the editorial team is alerted when major updates are made to the journal, journal policies or innovations. Editorial team members are elevated and thanked by means of speaking invitations, newsletters, participation in the annual ConV2X journal hosted symposium. A quarterly leadership meeting occurs to follow and enhance journal international progress and growth. Reviewers can obtain rewards through Publons and ReveiwerCredits. Annual and periodic outreach and 1:1 interviews are conducted by the publisher for journal and market feedback, trends and guidance. Editorial team members are encouraged to present new journal ideas and concepts to heighten audience engagement, journal education objectives, innovation and market prowess.

Disclosure of Unlabeled Use

Articles published by TMT may contain information and discussions of published and/or investigational uses of devices and agents that are not indicated by the Food and Drug Administrations (FDA).  Partners in Digital Health, publisher of TMT, does not recommend the use of any device or agent outside lawful and labeled indications.

Policy on content validation

  1. All the recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of animals and patients
  2. All scientific research referred to, reported, or used in a patient care recommendation must conform to accepted standards of experimental design, protocols, data collection and analysis

Patient consent

As recommended by the International Committee of Medical Journal Editors (http://www.icmje.org/). Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, 01/02/2018.  Available from: http://www.ICMJE.org., authors will ensure the guidelines below are followed. TMT has quoted the text below from ICMJE Protection of Research Participants for authors to know and follow:

"Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.

Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is usually inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article."

Statistical analyses

Ensure the methodology has been accurately described for statistical analysis. Include details and access to original data to verify results. Provide confidence levels, and define terms and symbols.  Include software used. In comparative studies, power calculations are usually required. In research manuscripts, requiring complex statistics, the advice of an expert statistician should be sought at the design/implementation stage of the study. It is appropriate to include statisticians as co-authors. Should you have further questions, please contact the managing editor.

Data sharing and reproducibility and data repositories

TMT time stamps all articles, meta data and supplementary research data submitted on the distributed ledger in partnership with Artifacts.ai and provides authors with a custom dashboard to independently manage and add additional research data sets. TMT encourages all authors around the globe to openly share data for purposes of reproducibility. TMT also asks authors and readers to share articles to encourage broadening the sector’s knowledge base.

TMT suggests authors include a data sharing statement when making a submission explaining:

  • What additional unpublished data from the study is available
  • Who can access the data and how can it be obtained

TMT encourages uploading code at Code Ocean, a cloud-based computational reproducibility platform. We encourage you to include your code with your manuscript submission for peer review, as well as publish this code to share with all upon article acceptance.

In addition, Dryad has declared its willingness to accept medical datasets. Figshare, Mendeley Data and Open Science Framework  may be considered. To explore other certified data repositories, see  FAIRsharing or re3data.org.

Be sure to select a repository that issues a Digital Object Identifier (DOI) and has a preservation plan for perpetuity. Researchers are encouraged to  consider FAIR Data Principles when depositing data.

Self-archiving of papers

When a manuscript is accepted authors are permitted to self-archive the accepted work (post-peer reviewed version, but preceding copy-editing and typesetting) on their own personal website and/or in funder or institutional repositories, for public release.

Authors may deposit the published version immediately on publication, without embargo. A link to TMT’s website is required to ensure integrity, authenticity and provenance of the scientific record, with the online published version identified as the incontrovertible version of record and include the DOI number. 

IP

The copyright owner retains all rights to IP, patents, and trademarks for their work(s). All rights to the owner of IP, patents and trademarks are retained by the owner. Sharing articles for professional and personal use is strongly encouraged.

Post publication discussion and corrections

TMT encourages collegiate discourse and transparency to assist the expansion of the body of knowledge and understanding within and beyond the sector. This can only be achieved with the highest ethical principles for education and science.

Ethical Publishing Practices

Submitted manuscripts should be exclusively submitted to TMT, with the understanding they have not been published elsewhere, in any form, and will not be submitted elsewhere, unless declined by TMT. Authors are responsible for all statements made in the article and references cited.

Misconduct - for details see https://telehealthandmedicinetoday.com/index.php/journal/ethics

TMT strives to abide by the guidelines and standards prescribed by Committee on Publication Ethics (COPE), its Code of Conduct, and its Best Practice Guidelines.

  • Authors are expected to be aware of, and comply with, best practice in publication ethics specifically but not limited to, dual submission, plagiarism, manipulation of figures, competing interests, and compliance with policies on research ethics.
  • Reviewers and editors are required to treat manuscripts fairly and in confidence, and to declare competing interests.

TMT will investigate allegations of misconduct and will contact author institutions, funders or regulatory bodies, as needed.

TMT will follow COPE flowcharts and seek guidance as per COPE recommendations on resolving issues that may arise. Evidence of misconduct may require corrective action by issuing a correction or retraction.

Address concerns regarding misconduct to a journal Editor-in-Chief, Publisher, or Managing Editor, at info@partnersindigitalhealth.com. We will address the issue with all appropriate person(s) as soon as possible, and send responses to confirm receipt of alleged misconduct.

Additional resources on publication ethics are available from COPEICMJE, and WAME